Postoperative Replacement of Intraoperative Iron Losses (POREIIL)
Blood Loss Anemia
About this trial
This is an interventional treatment trial for Blood Loss Anemia focused on measuring Anemia, Ferric carboxymaltose, intravenous iron, intraoperative blood loss, patient blood management, Red blood cell transfusion, postoperative iron replacement
Eligibility Criteria
Inclusion Criteria:
patients undergoing non-emergency
- cardiac surgery - obstetric surgery - intra-abdominal surgery
preoperative Hb (during the premedication visit):
- ♂: Hb>12.5g/dl
- ♀: Hb>11.5g/dl
postoperative Hb (immediately after surgical procedure in the recovery room):
- 2 g/dl below preoperative Hb concentration
- age ≥ 18 years
- Admission to intensive care unit or post-anesthesia care unit
- Able to sign consent for the trial
Exclusion Criteria:
- age < 18 years
- emergency surgery
- perioperative application of iron and/or erythropoietin
- intraoperative transfusion of allogeneic erythrocytes
- known hemochromatosis
- known allergic reaction linked to iron medication
Sites / Locations
- Universitätsklinik für Anästhesie und IntensivmedizinRecruiting
Arms of the Study
Arm 1
Arm 2
Active Comparator
Placebo Comparator
Intervention
Placebo
due to postoperative Hemoglobin Level intravenous iron Ferriccarboxymaltose is Infuses, dosage is based on the Ganzoni-Algorithm
Natriumchlorid is the placebo